VALNEVA (EPA:VLA) | WebDisclosure

Basculer en Français

10680	Companies
227999	Keywords
156510	Articles
120873	Press releases

Home
Companies
VALNEVA

PRESS RELEASE

published on 08/26/2025 at 11:25, 10 months 8 days ago

Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates Valneva SE (ISIN: FR0004056851) with BUY rating & reduced target price to EUR 6.30. FDA suspends Valneva's chikungunya vaccine; VLA15 Lyme disease vaccine prospects remain positive

First Berlin Equity Research BUY Rating Valneva SE Chikungunya Vaccine Lyme Disease VLA15
BRIEF

published on 08/25/2025 at 07:05, 10 months 10 days ago

FDA suspends IXCHIQ® license in the United States

FDA Suspension Vaccine Chikungunya IXCHIQ®
BRIEF

published on 08/25/2025 at 07:05, 10 months 10 days ago

Suspension par la FDA de la licence d'IXCHIQ® aux États-Unis

FDA Suspension Vaccin Chikungunya IXCHIQ®
PRESS RELEASE

published on 08/25/2025 at 07:00, 10 months 10 days ago

Valneva Announces FDA’s Decision to Suspend License of Chikungunya Vaccine IXCHIQ® in the U.S.
Valneva SE announces FDA's suspension of IXCHIQ® chikungunya vaccine license in the U.S. due to serious adverse events, despite reported cases consistent with clinical trials. Sales impact to be evaluated

FDA Valneva SE Chikungunya Vaccine License Suspension Serious Adverse Events
PRESS RELEASE

published on 08/25/2025 at 07:00, 10 months 10 days ago

Valneva annonce la décision de la FDA de suspendre la licence d’IXCHIQ® aux États-Unis
La FDA suspend la licence d'IXCHIQ® aux États-Unis en raison d'effets indésirables graves liés au chikungunya. Valneva analyse les cas et reste engagée à assurer la sécurité des vaccins

FDA Valneva Suspension Chikungunya IXCHIQ
BRIEF

published on 08/19/2025 at 10:44, 10 months 15 days ago

First Berlin maintient sa recommandation d'achat sur Valneva malgré de solides résultats au deuxième trimestre

Valneva SE Acheter Une Note Vaccin Contre La Maladie De Lyme Résultats Du Deuxième Trimestre Vaccin Contre Le Chikungunya
BRIEF

published on 08/19/2025 at 10:44, 10 months 15 days ago

First Berlin Maintains Buy Rating for Valneva Amid Strong Q2 Results

BUY Rating Q2 Results Valneva SE Lyme Disease Vaccine Chikungunya Vaccine
PRESS RELEASE

published on 08/19/2025 at 10:39, 10 months 15 days ago

Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research GmbH has published a research update on Valneva SE, maintaining their BUY rating and EUR 8.10 price target, following better-than-expected Q2/25 results and positive outlook on vaccines

BUY Rating Research Update Q2 Results Valneva SE Vaccine Outlook
BRIEF

published on 08/18/2025 at 07:05, 10 months 17 days ago

Valneva's IXCHIQ® Vaccine Authorized in Canada for Ages 12 and Older

Health Canada Valneva Vaccine Authorisation Chikungunya
BRIEF

published on 08/18/2025 at 07:05, 10 months 17 days ago

Le Vaccin IXCHIQ® de Valneva Autorisé au Canada pour les 12 Ans et Plus

Valneva Santé Canada Autorisation Vaccin Chikungunya

Accesswire

Published on 07/03/2026 at 23:00, 11 hours 15 minutes ago

Eagle Plains Partner Refined Energy Announces Final Results for Winter 2026 Drill Program at Dufferin West
Published on 07/03/2026 at 23:00, 11 hours 15 minutes ago

Medicure Announces CFO Change
Published on 07/03/2026 at 21:28, 12 hours 47 minutes ago

Trifecta Gold Announces Closing of $1.66 Million Private Placement
Published on 07/03/2026 at 19:30, 14 hours 45 minutes ago

Polaris Renewable Energy Announces Q2 2026 Investor Call Details
Published on 07/03/2026 at 13:30, 20 hours 45 minutes ago

Nextech3D.ai Unveils Strategic AI Growth Roadmap Focused on Workforce Intelligence and Event Technology Innovation

View all ACCESSWIRE

EQS Group

Published on 07/04/2026 at 09:05, 1 hour 10 minutes ago

Velo x McLaren Mastercard Formula 1® Team Relaunches Live Your Fandom to Bring Fans Closer to the Sport They Love
Published on 07/03/2026 at 19:00, 15 hours 15 minutes ago

PATRIMOINE ET COMMERCE: BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE AU 30 JUIN 2026
Published on 07/03/2026 at 18:55, 15 hours 20 minutes ago

Saudia Arabia's Mabani Aljazeera Group invests in Tatu City's Jabali Towers development
Published on 07/03/2026 at 18:14, 16 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 07/03/2026 at 18:00, 16 hours 15 minutes ago

Charwood Energy: W&nergy, a subsidiary of Charwood Energy, is launching a €2 million crowdfunding campaign on Enerfip.

Les Echos

Published on 07/03/2026 at 21:49, 12 hours 25 minutes ago

Safran annonce la fin des négociations concernant le projet d'acquisition d’Exail Technologies.
Published on 07/03/2026 at 21:49, 12 hours 25 minutes ago

Safran announces the end of negotiations regarding the contemplated acquisition of Exail Technologies.
Published on 07/03/2026 at 18:42, 15 hours 33 minutes ago

Total number of voting rights and shares making up the share capital at June 30, 2026
Published on 07/03/2026 at 18:42, 15 hours 33 minutes ago

Capital et droits de vote au 30 juin 2026
Published on 07/03/2026 at 18:36, 15 hours 38 minutes ago

Disclosure of transactions in own shares from July 1 to July 3, 2026

View all LES ECHOS COMFI WIRE